Parexel Solutions

  1. Portfolio Optimization Strategic Consulting 5/5/2026

    For each prospective compound, we help you think through its clinical implications, safety parameters, and side effects to establish what will differentiate it in the current market landscape. With multiple drugs and limited funds, you need to choose the right products early. These best prospects will then generate cash and asset value to develop others.

    In partnership with Health Advances, we’ll help you decide which investments will get you to an early proof of concept, which assets to advance and which to hold back, and which assets have synergies with others, whether in production, use, or market position. By the end of it all, you’ll have an effective, fully optimized portfolio.

  2. Drug Safety And Pharmacovigilance Services 4/2/2026

    Navigating drug safety in the era of innovation-driven medicine

    The focus on drug safety and pharmacovigilance has never been more intense. Patient safety remains paramount throughout a product's lifecycle, even as sponsors and marketing authorization holders (MAHs) face increasing complexity in managing safety data. This complexity stems from huge volumes of data generated from scores of diverse sources, much of it rapidly expanding unstructured data. Innovation-driven medicine is a key factor. These dynamics are reshaping the landscape of drug safety, presenting both challenges and opportunities for innovation in pharmacovigilance practices.

  3. AI-Powered Workflows: Accelerating Trial Execution 4/1/2026

    What can 22,000 people with an AI-mindset accomplish?

    Speed without shortcuts

    AI in clinical development at Parexel enables our teams to surface predictive insights at every stage, reducing protocol risk, study delays, and costly trial amendments.

    Parexel's approach to AI in clinical development is built on the Precision Pathway, a strategic operating model that embeds AI across the full trial lifecycle. AI empowers our teams at critical decision points to:

    1. Simplify complex tasks to accelerate timelines: AI capabilities are delivering up to 50% cycle time reductions in IND submission generation.
    2. Apply insights with agility to enable better decision-making
    3. Enhance data handling to drive first-time quality through content generation and workflow automation
  4. Protocol-Driven, Customized Site Solution Strategy

    Accelerate study start-up with the right sites, patients, and partnerships

    As protocols become more complex and sites face new pressures, your site selection strategy needs to be more nuanced than ever before. At Parexel, we bring that nuance and precision with the help of our Site Alliance Strategists, Community Alliance Network and Launch Excellence Office — a team who are committed to launching your projects quickly and efficiently with expertise in all key functions in clinical development strategy, planning, oversight, and delivery execution.

  5. Early Development And Innovation

    Where better medicines begin

    Early phase decisions are mission critical to the long-term success of your promising innovations. Learn how Parexel’s multi-disciplinary early phase approach can bolster your clinical evidence, accelerate the path to proof of concept and reduce the white space between early and late phase development, so you can deliver high impact therapies to patients sooner.